Voice Your Opinion on NICE Decision to Reject Vemurafenib for UK Patients.
Following an appraisal earlier in the year, NICE have now given their recommendations on the use of Vemurafenib for late stage melanoma patients.
Comments to NICE are invited, and anyone can comment, including NON-UK citizens.
Note: closing date for comments: 7 July 2012
